Abstract
Chondrogenesis results in the formation of cartilages, initial skeletal elements that can serve as templates for endochondral bone formation. Cartilage formation begins with the condensation of mesenchyme cells followed by their differentiation into chondrocytes. Although much is known about the terminal differentiation products that are expressed by chondrocytes1,2,3, little is known about the factors that specify the chondrocyte lineage4,5,6. SOX9 is a high-mobility-group (HMG) domain transcription factor that is expressed in chondrocytes and other tissues7,8,9,10,11,12. In humans, SOX9 haploinsufficiency results in campomelic dysplasia, a lethal skeletal malformation syndrome, and XY sex reversal7,13,14,15,16. During embryogenesis, Sox9 is expressed in all cartilage primordia and cartilages, coincident with the expression of the collagen α1(II) gene (Col2a1; refs 8,11, 12). Sox9 is also expressed in other tissues, including the central nervous and urogenital systems8,9,10,11,12. Sox9 binds to essential sequences in the Col2a1 and collagen α2(XI) gene (Col11a2) chondrocyte-specific enhancers and can activate these enhancers in non-chondrocytic cells17,18,19. Here, Sox9 is identified as a regulator of the chondrocyte lineage. In mouse chimaeras, Sox9-/- cells are excluded from all cartilages but are present as a juxtaposed mesenchyme that does not express the chondrocyte-specific markers Col2a1, Col9a2, Col11a2 and Agc. This exclusion occurred cell autonomously at the condensing mesenchyme stage of chondrogenesis. Moreover, no cartilage developed in teratomas derived from Sox9-/- embryonic stem (ES) cells. Our results identify Sox9 as the first transcription factor that is essential for chondrocyte differentiation and cartilage formation.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
SOX9 is a key component of RUNX2-regulated transcriptional circuitry in osteosarcoma
Cell & Bioscience Open Access 25 July 2023
-
Dysregulation of histone modifications in bone marrow mesenchymal stem cells during skeletal ageing: roles and therapeutic prospects
Stem Cell Research & Therapy Open Access 25 June 2023
-
High-glutathione mesenchymal stem cells isolated using the FreSHtracer probe enhance cartilage regeneration in a rabbit chondral defect model
Biomaterials Research Open Access 31 May 2023
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout





References
Stockwell, R.A. in Biology of Cartilage Cells (Cambridge University Press, Cambridge, UK, 1979).
Hall, B. & Newman, S. in Cartilage: Molecular Aspects (CRC Press, Boca Raton, Florida, 1991).
Mundlos, S. & Olsen, B.R. Heritable diseases of the skeleton. Part I: molecular insights into skeletal development-transcription factors and signaling pathways. FASEB J. 11, 125 –132 (1997).
Cancedda, R., Descalzi Cancedda, F. & Castagnola, P. Chondrocyte differentiation. Int. Rev. Cytol. 159, 265–358 (1995).
Erlebacher, A., Filvaroff, E.H., Gitelman, S.E. & Derynck, R. Toward a molecular understanding of skeletal development. Cell 80, 371–378 ( 1995).
Mundlos, S. & Olsen, B.R. Heritable diseases of the skeleton. Part II: molecular insights into skeletal development-matrix components and their homeostasis. FASEB J. 11, 227– 233 (1997).
Wagner, T. et al. Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 79, 1111–1120 ( 1994).
Wright, E. et al. The Sry-related gene Sox-9 is expressed during chrondrogenesis in mouse embryos. Nature Genet. 9, 15–20 (1995).
Kent, J., Wheatley, S.C., Andrews, J.E., Sinclair, A.H. & Koopman, P. A male-specific role for SOX9 in vertebrate sex determination. Development 122 , 2813–2822 (1996).
Morais da Silva, S. et al. Sox9 expression during gonadal development implies a conserved role for the gene in testis differentiation in mammals and birds. Nature Genet. 14, 62–68 (1996).
Ng, L.-J. et al. Sox9 binds DNA, activates transcription, and coexpresses with type II collagen during chondrogenesis in the mouse. Dev. Biol. 183, 108–121 ( 1997).
Zhao, Q., Eberspaecher, H., Lefebvre, V. & de Crombrugghe, B. Parallel expression of Sox9 and Col2a1 in cells undergoing chondrogenesis. Dev. Dyn. 209, 377–386 (1997).
Hovmoller, M.L. et al. Campomelic dwarfism. A genetically determined mesenchymal disorder combined with sex reversal. Hereditas 86, 51–62 (1977).
Takahashi, H., Sando, I. & Masutani, H. Temporal bone histopathological findings in campomelic dysplasia. J. Laryngol. Otol. 106, 361– 365 (1992).
Foster, J.W. et al. Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 372 , 525–530 (1994).
Kwok, C. et al. Mutations in SOX9, the gene responsible for campomelic dysplasia and autosomal sex reversal. Am. J. Hum. Genet. 57, 1028–1036 (1995).
Bell, D.M. et al. Sox9 directly regulates the type-II collagen gene. Nature Genet. 16, 174–178 (1997).
Lefebvre, V., Huang, W., Harley, V.R., Goodfellow, P.N. & de Crombrugghe, B. SOX9 is a potent activator of the chondrocyte-specific enhancer of the proα1(II) collagen gene. Mol. Cell. Biol. 17, 2336–2346 ( 1997).
Bridgewater, L.C., Lefebvre, V. & de Crombrugghe, B. Chondrocyte-specific enhancer elements in the Col11a2 gene resemble the Col2a1 tissue-specific enhancer. J. Biol. Chem. 273, 14998–15006 (1998).
Widelitz, R.B., Jiang, T.X., Murray, B.A. & Chuong, C.M. Adhesion molecules in skeletogenesis: II. Neural cell adhesion molecules mediate precartilaginous mesenchymal condensations and enhance chondrogenesis. J. Cell Physiol. 156, 399–411 (1993).
Oberlender, S.A. & Tuan, R.S. Expression and functional involvement of N-cadherin in embryonic limb chondrogenesis. Development 120, 177–187 (1994).
Mountford, P. et al. Dicistronic targeting constructs: reporters and modifiers of mammalian gene expression. Proc. Natl Acad. Sci. USA 91, 4303–4307 (1994).
Behringer, R.R., Finegold, M.J. & Cate, R.L. Müllerian-inhibiting substance function during mammalian sexual development. Cell 79, 415 –425 (1994).
Abuin, A. & Bradley, A. Recycling selectable markers in mouse embryonic stem cells. Mol. Cell. Biol. 16, 1851–1856 (1996).
Hogan, B., Beddington, R., Costantini, F. & Lacy, E. in Manipulating the Mouse Embryo: A Laboratory Manual (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1994).
Wilkinson, D.G. & Nieto, M.A. Detection of messenger RNA by in situ hybridization to tissue sections and whole-mounts. Methods Enzymol. 225, 361–373 (1993).
Metsäranta, M., Toman, D., de Crombrugghe, B. & Vuorio, E. Specific hybridization probes for mouse type I, II, III and IX collagen mRNAs. Biochim. Biophys. Acta 1089, 241– 243 (1991).
Glumoff, V., Savontaus, M., Vehanen, J. & Vuorio, E. Analysis of aggrecan and tenascin gene expression in mouse skeletal tissues by northern and in situ hybridization using species specific cDNA probes. Biochim. Biophys. Acta 1219, 613– 622 (1994).
Elima, K. et al. Specific hybridization probes for mouse α2(IX) and α1(X) collagen mRNAs. Biochim. Biophys. Acta 1130, 78–80 (1992).
Robertson, E.J. in Teratocarcinomas and Embryonic Stem Cells: A Practical Approach (IRL Press, Oxford, UK, 1987).
Acknowledgements
We thank A. Bradley for AB-1 ES and SNL 76/7 STO cell lines; M. Wakamiya for IRES-lacZ-pA loxP-flanked PGKneobpA plasmid; E. Vuorio and L. Bridgewater for RNA in situ hybridization probes; D. Whitworth for assistance with embryos; H. Eberspaecher for advice on histology; G. Pinero for histological assistance; and A. Bradley, R. Johnson and V. Lefebvre for helpful comments on the manuscript. The anti-collagen II monoclonal antibody developed by T. Linsenmayer was obtained from the Developmental Studies Hybridoma Bank. This study was supported by NIH grants HD30284 to R.R.B. and AR42919 to R.R.B. and B. de C.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Bi, W., Deng, J., Zhang, Z. et al. Sox9 is required for cartilage formation. Nat Genet 22, 85–89 (1999). https://doi.org/10.1038/8792
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/8792
This article is cited by
-
High-glutathione mesenchymal stem cells isolated using the FreSHtracer probe enhance cartilage regeneration in a rabbit chondral defect model
Biomaterials Research (2023)
-
Dysregulation of histone modifications in bone marrow mesenchymal stem cells during skeletal ageing: roles and therapeutic prospects
Stem Cell Research & Therapy (2023)
-
SOX9 is a key component of RUNX2-regulated transcriptional circuitry in osteosarcoma
Cell & Bioscience (2023)
-
An exploratory study for tuft cells in the breast and their relevance in triple-negative breast cancer: the possible relationship of SOX9
BMC Cancer (2023)
-
SP7: from Bone Development to Skeletal Disease
Current Osteoporosis Reports (2023)